Sunil Healthcare Ltd
NSE: BSE: 537253
₹61.97
(-1.01%)
Thu, 02 Apr 2026, 01:57 pm
Market Cap635.49M
PE Ratio22.27
Dividend0
Health Technology
Pharmaceuticals: Major
24.5KSunil Healthcare Analysis
dividend
- Unable to evaluate Sunil Healthcare's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
- Unable to evaluate Sunil Healthcare's dividend against the top 25% market benchmark as the company has not reported any payouts.
health
- Sunil Healthcare has been profitable on average in the past, therefore cash runway is not a concern.
- Sunil Healthcare has been profitable on average in the past, therefore cash runway is not a concern.
- Debt is well covered by operating cash flow (30.4%, greater than 20% of total debt).
- Debt is covered by short term assets, assets are 1.4x debt.
- Sunil Healthcare's cash and other short term assets cover its long term commitments.
- Sunil Healthcare's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
- The level of debt compared to net worth has increased over the past 5 years (82.8% vs 107.7% today).
- Sunil Healthcare's level of debt (107.7%) compared to net worth is high (greater than 40%).
- High level of physical assets or inventory.
management
- Anil's remuneration is about average for companies of similar size in India.
- Anil's compensation has been consistent with company performance over the past year, both up more than 20%.
- The average tenure for the Sunil Healthcare management team is over 5 years, this suggests they are a seasoned and experienced team.
- The average tenure for the Sunil Healthcare board of directors is less than 3 years, this suggests a new board.
misc
- Sunil Healthcare is not covered by any analysts.
past
- Unable to compare Sunil Healthcare's 1-year earnings growth to the 5-year average as it is not currently profitable.
- Sunil Healthcare does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
- Sunil Healthcare used its assets less efficiently than the IN Pharmaceuticals industry average last year based on Return on Assets.
- It is difficult to establish if Sunil Healthcare improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
- It is difficult to establish if Sunil Healthcare has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
- Unable to compare Sunil Healthcare's 1-year growth to the IN Pharmaceuticals industry average as it is not currently profitable.
value
- Sunil Healthcare's share price is below the future cash flow value, and at a moderate discount (> 20%).
- Sunil Healthcare is good value based on assets compared to the IN Pharmaceuticals industry average.
- Sunil Healthcare's share price is below the future cash flow value, but not at a substantial discount (< 40%).
- Sunil Healthcare is loss making, we can't compare its value to the IN Pharmaceuticals industry average.
- Sunil Healthcare is loss making, we can't compare the value of its earnings to the India market.
- 537253 underperformed the Pharmaceuticals industry which returned 26.7% over the past year.
- 537253 underperformed the Market in India which returned -14.5% over the past year.
- BSE:537253 is flat (-0.5%) underperforming the Pharmaceuticals industry which returned 6.8% over the past month.
- BSE:537253 is flat (-0.5%) underperforming the market in India which returned 8% over the past month.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800